Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 15, 2018Transplant InternationalOpen Access

Donor-specific HLA antibody-mediated complement activation is a significant indicator of antibody-mediated rejection and poor long-term graft outcome during lung transplantation: a single center cohort study

View Full Paper
Ask AI
Bookmark
Share

Authors

ARAntoine RouxUniversity of Cape TownKTKimberly A. ThomasVitalantÉSÉdouard SageUniversité Paris-Sud

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Roux et al. (2018) studied this question.

synapsesocial.com/papers/6aaba7107562f7663651eeb2https://doi.org/10.1111/tri.13149
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Immunoadsorption in Severe C4d-Positive Acute Kidney Allograft Rejection: A Randomized Controlled Trial2006 · 140 citations
  2. 2Detection of C3d-Binding Donor-Specific Anti-HLA Antibodies at Diagnosis of Humoral Rejection Predicts Renal Graft Loss2014 · 266 citations
  3. 3Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation2017 · 100 citations